A £1 million crowdfunding campaign launched by PHARMASEAL to revolutionise global clinical trials …
Dare to dream?
Invest in PHARMASEAL and our mission to transform how Clinical Trials are managed by hundreds of SME companies developing new medicines for human health.
Approved by Seedrs. Capital at Risk.
Intelligent Engineering for Clinical Trial Management
Engility® has been designed and developed utilising agile engineering practices with extensive automation to ensure that validation assets can be generated with higher accuracy and quality utilising the PHARMASEAL continuous validation framework.
Our automated continuous validation framework reduces the time it takes to validate the system. Whilst validation is required in a regulated industry, our approach allows us to increase the pace of innovation in a controlled way. Innovative systems that are engineered for change offer extensive automation to deliver new features in a regulated industry, faster than current products. Intuitive systems that utilize flexible cloud architecture allow biopharmaceutical and medical device companies of all sizes to leverage affordable enterprise technology to fit their individual organisation model, expediating clinical development.
PHARMASEAL was founded in 2016 by a team of industry leaders who share a vision to create smarter technologies and innovative products for the improvement of human health.
The company’s Engility® platform simplifies the management and control of clinical trials for biopharmaceutical and medical device companies. Engility utilises advanced engineering offering enterprise management with rapid deployment, an intuitive user interface and interoperability with other eClinical applications to optimise trial governance and oversight.
Manage Your Clinical Trials Better With Engility®Contact us
An Opportunity to Shape the Future of Clinical Trials: PHARMASEAL Launches £1 million Crowdfunding Campaign
PHARMASEAL, a new provider of clinical trial management and governance solutions, today announces …
Engility®CTMS Selected by Leading US Health Outcomes and Technology Company for its Clinical Trial Programmes
PHARMASEAL, a new provider of clinical trial management and governance solutions, announced today …